New York State Common Retirement Fund’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.6M Buy
65,424
+1,000
+2% +$340K 0.03% 400
2025
Q4
$25.6M Hold
64,424
0.03% 343
2025
Q3
$29.4M Buy
64,424
+1,152
+2% +$469K 0.04% 316
2025
Q2
$20.6M Sell
63,272
-1,000
-2% -$277K 0.03% 432
2025
Q1
$17.4M Sell
64,272
-7,956
-11% -$2.04M 0.03% 491
2024
Q4
$17M Sell
72,228
-4,000
-5% -$1.05M 0.02% 533
2024
Q3
$21M Sell
76,228
-18,457
-19% -$4.81M 0.03% 473
2024
Q2
$23M Buy
94,685
+919
+1% +$145K 0.03% 445
2024
Q1
$14M Sell
93,766
-18,148
-16% -$3.03M 0.02% 680
2023
Q4
$21.4M Sell
111,914
-13,049
-10% -$2.22M 0.03% 506
2023
Q3
$22.1M Sell
124,963
-17,156
-12% -$3.27M 0.03% 455
2023
Q2
$27M Sell
142,119
-5,969
-4% -$1.18M 0.03% 446
2023
Q1
$29.7M Sell
148,088
-6,610
-4% -$1.39M 0.04% 407
2022
Q4
$36.8M Buy
154,698
+6,680
+5% +$1.42M 0.05% 328
2022
Q3
$29.6M Sell
148,018
-5,106
-3% -$974K 0.04% 381
2022
Q2
$22.3M Sell
153,124
-33,576
-18% -$4.76M 0.03% 492
2022
Q1
$30.5M Sell
186,700
-941
-0.5% -$143K 0.03% 448
2021
Q4
$31.8M Buy
187,641
+6,717
+4% +$1.25M 0.03% 460
2021
Q3
$34.2M Sell
180,924
-3,196
-2% -$600K 0.04% 439
2021
Q2
$31.2M Sell
184,120
-334
-0.2% -$48.9K 0.03% 487
2021
Q1
$26M Sell
184,454
-14,100
-7% -$2.12M 0.03% 551
2020
Q4
$25.8M Sell
198,554
-21,200
-10% -$2.83M 0.03% 543
2020
Q3
$32M Sell
219,754
-22,795
-9% -$3.24M 0.04% 418
2020
Q2
$35.9M Buy
242,549
+2,320
+1% +$313K 0.05% 366
2020
Q1
$26.1M Sell
240,229
-13,091
-5% -$1.51M 0.04% 426
2019
Q4
$29.2M Sell
253,320
-7,513
-3% -$749K 0.03% 494
2019
Q3
$21M Buy
260,833
+19,071
+8% +$1.51M 0.03% 608
2019
Q2
$17.5M Buy
241,762
+18,399
+8% +$1.41M 0.02% 722
2019
Q1
$20.9M Buy
223,363
+11,202
+5% +$937K 0.03% 630
2018
Q4
$15.5M Buy
212,161
+5,353
+3% +$412K 0.02% 700
2018
Q3
$18.1M Buy
206,808
+3,827
+2% +$385K 0.02% 749
2018
Q2
$20M Sell
202,981
-12,500
-6% -$1.24M 0.03% 687
2018
Q1
$25.7M Sell
215,481
-1,600
-0.7% -$206K 0.03% 552
2017
Q4
$27.6M Buy
217,081
+593
+0.3% +$74.5K 0.03% 527
2017
Q3
$25.4M Buy
216,488
+13,500
+7% +$1.15M 0.03% 530
2017
Q2
$16.2M Sell
202,988
-10,263
-5% -$656K 0.02% 740
2017
Q1
$10.9M Buy
213,251
+33,397
+19% +$1.54M 0.01% 920
2016
Q4
$6.73M Sell
179,854
-35,423
-16% -$1.48M 0.01% 1114
2016
Q3
$14.6M Sell
215,277
-14,700
-6% -$1.04M 0.02% 733
2016
Q2
$12.8M Buy
229,977
+8,400
+4% +$529K 0.02% 813
2016
Q1
$13.9M Sell
221,577
-3,300
-1% -$219K 0.02% 756
2015
Q4
$21.2M Buy
224,877
+19,154
+9% +$1.78M 0.03% 567
2015
Q3
$16.5M Buy
205,723
+70,201
+52% +$7.8M 0.03% 660
2015
Q2
$16.2M Buy
135,522
+98,728
+268% +$11.8M 0.02% 696
2015
Q1
$3.84M Sell
36,794
-4,329
-11% -$439K 0.01% 1345
2014
Q4
$3.99M Sell
41,123
-90,131
-69% -$8.35M 0.01% 1315
2014
Q3
$10.3M Sell
131,254
-3,735
-3% -$241K 0.02% 888
2014
Q2
$8.53M Buy
134,989
+13,349
+11% +$793K 0.01% 1013
2014
Q1
$8.17M Buy
121,640
+36,623
+43% +$2.84M 0.01% 1013
2013
Q4
$5.47M Buy
85,017
+12,517
+17% +$747K 0.01% 1177
2013
Q3
$4.64M Buy
+72,500
New +$3.61M 0.01% 1209

Other funds holding ALNY